Serum dolichols in chronic cholestatic liver diseases

Journal of Hepatology

Volumn 31, Issue 6, 1999, Pages 1014-1019

  Humaloja, Kari ^c   Roine, Risto P ^c   Vuoristo, Matti ^c   Färkkilä, Martti ^a   Höckerstedt, Krister ^a   Salaspuro, Mikko ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NONE

Author keywords

Dolichol; Liver diseases; Serum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; BETA N ACETYLHEXOSAMINIDASE; BILIRUBIN; CHOLESTEROL; DOLICHOL; GAMMA GLUTAMYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PREALBUMIN; TRIACYLGLYCEROL;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILIARY EXCRETION; CHOLESTEROL BLOOD LEVEL; CHRONIC ACTIVE HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; THROMBOPLASTIN TIME;

EID: 0032712427     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80313-4     Document Type: Article

References (32)

1. Rip JW, Rupar CA, Ravi K, Carroll KK. Distribution, metabolism and function of of dolichol and polyprenols. Prog Lipid Res. 24:1985;269-309.
2. Chojnacki T, Dallner G. The biological role of dolichol. Biochem J. 251:1988;1-9.
3. Keller RK. Dolichol metabolism in the rat. Trends Biochem Sci. 12:1987;443-445.
4. Rupar CA, Carrol KK. Occurrence of dolichols in human tissues. Lipids. 13:1978;291-293.
5. Elmberger PG, Kalen A, Appelqvist EL, Dallner G. In vitro and in vivo synthesis of dolichol and other main mevalonate products in various organs of the rat. Eur J Biochem. 168:1987;1-11.
6. Tollbom Ö, Dallner G. Dolichol and dolichyl phosphate in human tissues. Br J Exp Path. 67:1986;757-764.
7. Valtersson C, van Duyn G, Verkleij AJ, Chojnacki T, de Kruijjff B, Dallner G. The influence of dolichol, dolichol esters, and dolichyl phosphate on phospholipid polymorphism and fluidity in model membranes. J Biol Chem. 269:1985;2742-2751.
8. Schutzbach JS, Jensen JW, Lai C-S, Monti JA. Membrane structure and mannosyltransferase activities: the effects of dolichols on membranes. Chemica Scripta. 27:1987;109-118.
9. Salaspuro M, Salmela K, Humaloja K, Autio S, Arvio M, Palo J. Elevated levels of serum dolichol in aspartylglucosaminuria. Life Sci. 47:1990;627-632.
10. Jokelainen K, Salmela K, Humaloja K, Roine RP, Autio S, Arvio M, et al. Blood dolichol in lysosomal diseases. Biochem Cell Biol. 70:1992;481-485.
11. Roine RP, Nykänen I, Ylikahri R, Heikkilä J, Suokas A, Salaspuro M. Effect of alcohol on blood dolichol concentration. Alcoholism. 13:1989;519-522.
12. Elmberger PG, Engfeldt P, Dallner G. Presence of dolichol and its derivatives in human blood. J Lipid Res. 29:1988;1651-1662.
13. Humaloja K, Roine RP, Salmela K, Halmesmäki E, Jokelainen K, Salaspuro M. Serum dolichols in different clinical conditions. Scand J Clin Lab Invest. 51:1991;705-709.
14. Harry DS, McIntyre N. Plasma lipoproteins and the liver. Millward-Sadler GH, Wright R, Arthur MJR. Liver and Biliary Disease, vol. 1. 3rd ed. 1992;61-72 W.B. Saunders Company Ltd, London.
15. VanDessel G, DeWolf M, Lagrou A, Hilderson HJ, Dierick W. On the binding of dolichol by human serum. Biochim Biophys Acta. 787:1986;346-352.
16. Elmberger PG, Kalen A, Brunk UT, Dallner G. Discharge of newly synthesized dolichol and ubiquinone with lipoproteins to rat liver perfusate and to the bile. Lipids. 24:1989;919-939.
17. Marino M, Bruscalupi G, Manzi P, Rivabene R, Trentalance A. Changes in plasma dolichol levels, transport and hepatic delivery during rat liver regeneration. Metabolism. 43:1994;677-680.
18. Humaloja K, Roine RP, Salaspuro M. Effects of Triton WR 1339 and Orotic acid on biliary and serum dolichols in rats. Metabolism. 47:1998;644-649.
19. VanDessel G, DeWolf M, Hilderson HJ, Lagrou A, Dierick W. Intra- and extracellular flow of dolichol. Subcell Biochem. 16:1990;227-278.
20. Eggens I, Chojnacki T, Kenne L, Dallner G. Separation, quantitation and distribution of dolichol and dolichyl phosphate in rat and human tissues. Biochim Biophys Acta. 751:1983;355-368.
21. Eggens I, Ekström TJ, Åberg F. Studies on the synthesis of polyisoprenols, cholesterol and ubiquinone in highly differentiated human hepatomas. J Exp Path. 71:1990;219-232.
22. Krill JJ, Pullarkat RK, Pullarkat PS, Harper CG. Brain and liver dolichol in chronic alcoholism. A necropsy study. Alcoholism. 14:1990;528-530.
23. Levvy GA, Conchie J. Mammalian glycosidases and their inhibition by aldonolactones. Neufeld EF, Ginsburg V. Methods in Enzymology. 1966;571-584 Academic Press, New York.
24. Pitkänen E, Kyllästinen M, Koivula T, Hormila P. Beta-n-acetylglucosaminidase activities in insulin dependent diabetic subjects with retinopathy. Diabetologia. 18:1980;275-278.
25. Jahn CE, Schaefer JE, Taam LA, Hoofnagle JH, Lindgren FT, Albers JJ, et al. Lipoprotein abnormalities in primary biliary cirrhosis. Gastroenterology. 89:1985;1266-1278.
26. Taskinen MR, Välimäki M, Nikkilä EA, Kuusi T, Ehnholm C, Ylikahri R. High density lipoprotein subfractions and postheparin plasma lipases in alcoholic men before and after alcohol withdrawal. Metabolism. 31:1982;1168-1174.
27. Välimäki M, Nikkilä EA, Taskinen MR, Ylikahri R. Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis. 59:1986;147-153.
28. Humaloja K, Salaspuro M, Roine RP. Biliary excretion of dolichols - effect of ethanol and glucagon. Lipids. 32:1997;1169-1172.
29. Hultberg B, Isaksson A, Jansson L. β-Hexosaminidase in serum from patients with cirrhosis and cholestasis. Enzyme. 26:1981;296-300.
30. Elsafi M, Hultberg B, Isaksson A, Hägerstrand I, Prytz H, Stenram U. Lysosomes and human liver disease: a biochemical and immunohistochemical study of β-hexosaminidase. Eur J Clin Chem Clin Biochem. 32:1994;669-673.
31. Yasugi E, Oshima M. Sequential microanalyses of free, dolichol fatty acid ester and dolichyl phosphate levels in human serum. Biochim Biophys Acta. 121:1994;107-113.
32. Nikkilä K. Liver transplantation restores low serum levels of very low density and high density lipoproteins in end-stage primary biliary cirrhosis. Ann Med. 24:1992;129-136.